Spanish Validation of the Problem Area in Diabetes-Pediatric Version Survey and Its Weak Association with Metabolic

Elisa Civitani Monzón1,2, María Pilar Ferrer Duce1, Antonio De Arriba Muñoz1,2

  • 1Miguel Servet University Hospital, Avenida Isabel la Católica 1-3, 50009 Zaragoza, Aragón, Spain.

PubMed

Insights

The Spanish PAID-Peds survey reliably measures emotional distress in pediatric Type 1 diabetes patients. This validated tool can help identify emotional burden for improved diabetes management.

Area of Science:

  • Pediatric Endocrinology
  • Psychometrics
  • Diabetes Management

Background:

  • Pediatric Type 1 diabetes mellitus (T1DM) frequently causes emotional distress, negatively affecting self-care.
  • The PAID-Peds survey assesses diabetes-related emotional burden but lacks a validated Spanish version.
  • This study focused on validating the Spanish PAID-Peds survey for pediatric T1DM patients.

Purpose of the Study:

  • To validate the Spanish version of the PAID-Peds survey for children and adolescents with T1DM.
  • To assess the reliability and construct validity of the Spanish PAID-Peds survey.
  • To explore the correlation between emotional burden scores and metabolic control in pediatric T1DM.

Main Methods:

  • Cross-sectional study involving 538 pediatric patients (aged 8-17) with T1DM from three Spanish hospitals.
  • Psychometric evaluation included Cronbach's alpha for internal consistency and confirmatory factor analysis for construct validity.
  • Analysis of associations between PAID-Peds scores and clinical parameters like HbA1c.

Main Results:

  • The Spanish PAID-Peds survey demonstrated high internal consistency (Cronbach's alpha = 0.90).
  • Confirmatory factor analysis confirmed a satisfactory model fit, supporting construct validity.
  • A weak but statistically significant correlation was observed between PAID-Peds scores and HbA1c levels (r = 0.14, p < 0.001).

Conclusions:

  • The Spanish PAID-Peds survey is a psychometrically sound and reliable instrument for evaluating emotional burden in pediatric T1DM.
  • Clinical implementation can facilitate early detection of emotional distress, potentially enhancing diabetes self-management.
  • Future research should investigate longitudinal applications and its utility in intervention studies.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
500
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
233
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
854
Feedback Loops01:01

Feedback Loops

In most cases, excessive hormone production is prevented by negative feedback—a loop that starts with a stimulus inducing the release of a particular substance, like a hormone, to maintain a certain level before triggering a signal that results in a decrease in further release of the hormone.
55.7K